Bausch & Lomb awards 5,255 RSUs to director

Bausch & Lomb Corp reported that director Steven H. Collis acquired 5,255 common shares through an annual grant of restricted share units (RSUs) for non-employee directors.

Rhea-AI Filing Summary

Bausch & Lomb Corp reported that director Steven H. Collis acquired 5,255 common shares through an annual grant of restricted share units (RSUs) for non-employee directors. The RSUs were granted at no cash cost and are scheduled to vest immediately before the company’s next annual shareholder meeting.

Insider Trade Summary

Grant/Award: 5,255 shares

Grant/Award 1 txn

Insider COLLIS STEVEN H

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares, No Par Value	5,255	$0.00	$0.00

Holdings After Transaction: Common Shares, No Par Value — 5,255 shares (Direct)

Footnotes (1)

1. F1. Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did BLCO director Steven H. Collis report?

Director Steven H. Collis reported receiving an annual equity award of 5,255 restricted share units. These RSUs are part of Bausch & Lomb’s 2022 Omnibus Incentive Plan for non-employee directors and are settled in common shares when they vest before the next annual shareholder meeting.

How many Bausch & Lomb (BLCO) shares are involved in the latest Form 4?

The Form 4 shows an award relating to 5,255 common shares via restricted share units. These RSUs represent Collis’s annual non-employee director grant and will be settled in Bausch & Lomb common shares when they vest immediately prior to the company’s next annual shareholder meeting.

Was the BLCO director’s RSU grant a purchase or a compensation award?

The transaction is a compensation award, not a market purchase. Collis received 5,255 restricted share units as his annual non-employee director grant at a stated price of $0.00 per share under Bausch & Lomb’s 2022 Omnibus Incentive Plan, as amended and restated.

When do Steven H. Collis’s BLCO RSUs vest?

The restricted share units granted to Steven H. Collis are scheduled to vest immediately before Bausch & Lomb’s next annual meeting of shareholders. Upon vesting, the RSUs will be settled in common shares of the company, increasing his direct equity holdings accordingly under the incentive plan.

What plan governs the BLCO director’s 5,255 RSU award?

The 5,255 restricted share units were granted under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. This plan covers equity-based compensation for eligible participants, including non-employee directors who receive annual RSU awards instead of cash-only compensation for board service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/23/2026 - 04:19 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

COLLIS STEVEN H

(Last) (First) (Middle)

C/O BAUSCH + LOMB CORPORATION

520 APPLEWOOD CRESCENT

(Street)

VAUGHN A6 L4K 4B4

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bausch & Lomb Corp [ BLCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, No Par Value	02/19/2026		A		5,255(1)	A	$0	5,255	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders.

	/s/ Debra E. Levin, attorney-in-fact	02/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.